Skip to content

Ardelyx ARDX Price / sales

Price / sales at other companies

Amgen logo
AmgenAMGN
5.1×+0.2×
Bausch Health Companies logo
Bausch Health CompaniesBHC
0.2×-0.1×
AbbVie logo
AbbVieABBV
6.1×-0.3×
XER
Xeris Biopharma Holdings, Inc.XERS
3.2×-0.6×
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
7.7×+0.5×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
4.3×-0.3×

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+25.5%
Enterprise value$1.71B+27.1%

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Ardelyx’s reported figures.

Based on the most recent quarter.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's price / sales?
Ardelyx (ARDX) reported price / sales of 3.4× in Q1 2026.
How has Ardelyx's price / sales changed year-over-year?
Ardelyx's price / sales increased by 6.2% year-over-year, from 3.2× to 3.4×.
What is the long-term trend for Ardelyx's price / sales?
Over 5 years (2020 to 2025), Ardelyx's price / sales has grown at a -48.5% compound annual growth rate (CAGR), from 96.3× to 3.5×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.